Erin K. Copeland to Speak at Upcoming CPAP Conference
Fibich, Leebron, Copeland & Briggs Partner Featured Speaker at HarrisMartin’s MDL Conference Fibich, Leebron, Copeland & Briggs is proud to…
Read More
Erin Copeland Selected to Lead Multidistrict Litigation Against Teva in Massive Paragard IUD Lawsuit
MDL Consolidates More Than 100 Cases Against Makers of Birth Control Device Paragard District Judge Leigh Martin May has selected…
Read More
Greg Fibich Named Life Fellow of the Texas Bar Foundation
Fellows of the Texas Bar Foundation Represent Texas’ Top Legal Advocates Fibich, Leebron, Copeland & Briggs is pleased to announce…
Read More
Erin Copeland Named Litigator of the Week by The American Lawyer
Litigators of the Week: The Plaintiffs’ Team Behind the $1.6B Essure Settlement Bayer AG last week announced a proposed $1.6…
Read More
Erin Copeland Helps Negotiate Essure® Settlement for $1.6 Billion
Firm Partner Erin Copeland Helps Lead Essure Lawsuit to Victory as a Lead Member of the JCCP Executive Committee On…
Read More
Attorney Greg Fibich Selected to 2019 Texas Rising Stars List
At Fibich, Leebron, Copeland & Briggs, we always strive to provide the highest level of client service and powerful legal…
Read More
Attorney Fibich Wins 2019 Ronald D. Secrest Award from Texas Bar
For more than 45 years, our founder Tommy Fibich has applied his unrelenting work ethic and passion for the law to help…
Read More
April is Sexual Assault Awareness Month
Sexual violence is a serious public health problem that impacts hundreds of thousands of Americans each year. As a term,…
Read More
Tommy Fibich Selected as 2019 Recipient of the Ronald D. Secrest Outstanding Trial Lawyer Award
Fibich, Leebron, Copeland & Briggs Founding Partner Tommy Fibich has been selected as the recipient of the 2019 Ronald D.…
Read More
Attorney Fibich Mentioned in Houston Public Media Article on Opioid Epidemic
A year ago, Harris County made the decision to file a lawsuit against 21 different drug manufacturers as well as four doctors…
Read More
1 2 3 4

© 2020 All Rights Reserved.